Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

7.84
+0.61938.58%
Volume:7.93M
Turnover:60.37M
Market Cap:1.27B
PE:2.64
High:7.85
Open:7.32
Low:7.29
Close:7.22
Loading ...

Novavax Says Company Is Aligned With Activist Investor on Measures Including Major Cost Cuts

Dow Jones
·
29 Apr

Novavax board ‘appreciates support of Shah Capital’

TIPRANKS
·
29 Apr

BRIEF-Novavax Board Of Directors Appreciates The Formal Support And Strategic Guidance Of Shah Capital

Reuters
·
29 Apr

Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot -- Barrons.com

Dow Jones
·
28 Apr

Confusion surrounds FDA’s delay in granting Novavax vaccine approval, STAT says

TIPRANKS
·
28 Apr

Market Chatter: Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine

MT Newswires Live
·
26 Apr

BUZZ-Novavax falls after report FDA demands new trial for COVID vaccine

Reuters
·
26 Apr

FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports

Reuters
·
26 Apr

Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports

TIPRANKS
·
26 Apr

Novavax asked by FDA to complete additional COVID trial, WSJ says

TIPRANKS
·
26 Apr

Stock Track | Novavax Shares Plummet 10.40% as FDA Demands New Clinical Trial for Delayed Covid-19 Vaccine

Stock Track
·
26 Apr

Stock Track | Novavax Shares Plummet 10.40% as FDA Demands New Clinical Trial for Covid-19 Vaccine

Stock Track
·
26 Apr

BRIEF-FDA Asks Vaccine Maker Novavax To Complete New Clinical Trial For Delayed Covid-19 Shot - WSJ

Reuters
·
26 Apr

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
25 Apr

Stock Track | Novavax Plummets 5% as FDA Delays COVID Vaccine Approval Amid Efficacy Concerns

Stock Track
·
24 Apr

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Zacks
·
24 Apr

Equity Markets Close Higher Over Potential Reduction in US Tariffs on China

MT Newswires Live
·
24 Apr

Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine

GuruFocus.com
·
24 Apr

Stock Track | Novavax Soars 17% as COVID-19 Vaccine Nears Potential FDA Approval

Stock Track
·
23 Apr

Novavax Says COVID Vaccine Application 'Approvable'

MT Newswires Live
·
23 Apr